The 20 Best Classical Hodgkin Lymphoma Doctors Near Me in Manhasset, NY

Douglas Gladstone is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Gladstone is rated as a Distinguished provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Hodgkin Lymphoma, and Bone Marrow Aspiration.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as a Distinguished provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Ruthee-lu Bayer is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Bayer is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bayer is board certified in American Board Of Internal Medicine.

Dr. Crina Vintila is an attending physician double board-certified in medical oncology and hematology, who has served the Long Island community for more than 20 years at the Don Monti Cancer Center at Glen Cove Hospital, Huntington Cancer Institute, and most recently, at the Monter Cancer Center.Being part of the Northwell Health System for more than 2 decades, her practice has focused on delivering individualized, evidence-based patient care, in a multidisciplinary setting, with active participation in research trials. She takes special interest in breast, gastrointestinal, and hematologic malignancies.Dr.Vintila earned her medical degree at the Institute of Medicine and Pharmacy, Bucharest, Romania. She completed internal medicine training at the Weil Cornell / NY Hospital -Booth Memorial Medical Center, and her hematology and medical oncology fellowship at Winthrop University Hospital.Dr.Vintila is fluent in Romanian, Spanish and French. Dr. Vintila is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Vintila is board certified in American Board Of Internal Medicine/Medical Oncology.

David Straus is a Hematologist practicing medicine in New York, New York. Dr. Straus is rated as an Elite provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Transplant.

Simon Prince is an Internal Medicine specialist and a Nephrologist practicing medicine in Manhasset, New York. Dr. Prince is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Classical Hodgkin Lymphoma. Dr. Prince is board certified in American Board Of Internal Medicine/Nephrology.

Summa cum laude graduate of the University of Missouri in Columbia, MO. Honors graduate of the Saint Louis University School of Medicine in St. Louis, MO. Chief Resident and graduate of the Hofstra - Northwell Radiology Residency in Manhasset, NY. Graduate of the University of North Carolina Vascular and Interventional Radiology Fellowship in Chapel Hill, NC. Currently an Assistant Professor of Radiology at the Zucker School of Medicine at Hofstra/Northwell, and Attending Interventional Radiologist at North Shore University Hospital and Long Island Jewish - Valley Stream. Special areas of expertise include vascular malformations, lymphatic malformations, trauma, and bronchial artery interventions. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Ascites, Pleurisy, Pleural Effusion, Gastrostomy, and Liver Embolization. Dr. Al is board certified in American Board Of Radiology.

Michael J. Drabkin, MD is the Chief of Interventional Radiology at NY Imaging / New York Cancer & Blood Specialists (NYCBS), serving Long Island and the greater New York City area. He is board-certified in both Diagnostic Radiology and Interventional Radiology.His practice focuses on minimally invasive, same-day treatments for enlarged prostate (BPH), uterine fibroids, varicoceles, and cancer. Dr. Drabkin performs more than 650 Prostate Artery Embolizations (PAE) per year, placing him among the highest-volume PAE physicians in the United States. He has performed over 20,000 image-guided procedures during his career.He completed his fellowship in Vascular and Interventional Radiology at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, where he served as Chief Fellow. He earned his undergraduate degree at Columbia University and his medical degree from SUNY Upstate Medical University.Dr. Drabkin is a Castle Connolly Top Doctor, and an active member of the Society of Interventional Radiology and the American Urological Association. He is well published in professional journals, and has been an invited speaker at national and international conferences. Dr. Drabkin is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Ascites, Familial Colorectal Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Liver Embolization. Dr. Drabkin is board certified in Interventional Radiology and Diagnostic Radiology. Dr. Drabkin is currently accepting new patients.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Jou is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome. Dr. Rai is board certified in American Board Of Pediatrics.

An internationally known leader in hematology, A. Samer Al-Homsi, MD, MBA, is system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute, where he also serves as director of faculty and academic affairs in medical oncology.In his position, Dr. Al-Homsi treats patients in need of blood and marrow transplantation for blood cancers and other blood conditions. Dr. Al-Homsi attended medical school at Damascus University Faculty of Medicine, did his residency at Advocate Christ Medical Center in Illinois, and completed a fellowship at UMass Chan Medical School in Worcester, MA. He also received training and practiced in France. He came to Northwell from the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, where he was executive director of transplantation and cellular therapy. His research efforts throughout his career have focused on innovations that lead to better patient care in blood and marrow transplantation.The poet Kahlil Gibran wrote that work is love made visible, and I believe medicine is love made visible, says Dr. Al-Homsi. Every patient has unique needs, based not just on their specific condition, but also on their cultural background, family situation, and the impact of their disease. We're fortunate at Northwell to have care delivered by a large team that's there to address all those aspects.Dr. Al-Homsi is looking forward to advancing more clinical research at Northwell's Feinstein Institutes for Medical Research and at Cold Spring Harbor Laboratory. That will likely facilitate the development of more therapies that can treat patients, he says, and in a way that's safer and more effective.Dr. Al-Homsi doesn't just focus on the physical effects of conditions like leukemia, lymphoma, and multiple myeloma with decades of patient care, he also knows the tremendous value of a deeper conversation about how cancer is affecting patients mental health and everyday function. His priority is to learn about the patient first and the disease second.That perspective on patient advocacy and approaching each interaction with compassion and love is the same now as it was when he first entered medical school, he recalls. I wanted my life to matter, and to make a difference, he says. I'm not trying to change the world, but I can change patients' lives. I can change their world, and that's incredibly rewarding and meaningful. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Adult T-Cell Leukemia, Chronic T-Cell Leukemia (CTCL), and Bone Marrow Transplant. Dr. Al is board certified in American Board Of Internal Medicine/Hematology.

Maria Jacqueline Nieto,MD,MSc is an Assistant Professor of Medicine at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell where she specializes in treating patients with benign and malignant hematological conditions.Dr Nieto is board certified in Internal Medicine and Medical Oncology. Dr Nieto's clinical focus is on myelodysplastic syndromes, myeloproliferative disorders, and lymphomas. She is particularly interested in the care of the elderly with hematological malignancies, evaluating treatment disparities in cancer care, and optimizing cancer and palliative care at the end of life. She is co-investigator on multiple clinical trials focused on the treatment of patients with hematological malignancies. Dr Nieto has a Master of Science degree in Clinical Research from New York University.Dr Nieto is an active member in the American Society of Clinical Oncology and the American Society of Hematology and is fluent in Spanish. Dr. Nieto is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Bone Marrow Aspiration, and Tissue Biopsy.

Shams Shakil, MD, PhD, MS, is an attending physician based at the Monter Cancer Center where he specializes in the treatment of patients with benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Shakil is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Shakil maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He earned his medical degree from Chittagong Medical College in Bangladesh, his PhD from Hiroshima University School of Medicine and his MS in Medical Informatics from the Oregon Health and Science University. His fellowship in Hematology/Oncology was completed at Brookdale University Hospital Center. Dr. Shakil has a research background in both surgical oncology and radiation oncology. He is an active member of the American Society of Hematology. Dr. Shakil is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Anemia, Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.

Clary Evans is a Radiation Oncologist practicing medicine in Lake Success, New York. Dr. Evans is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, and Breast Cancer.

Samuel Singer is a Neurologist practicing medicine in Lake Success, New York. Dr. Singer is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Astrocytoma, Primitive Neuroectodermal Tumor (PNET), Bone Marrow Aspiration, and Tissue Biopsy.

Bradley Goldberg, MD, is an attending physician based at the Monter Cancer Center where he specializes in treating patients with both benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Goldberg maintains an active practice where he focuses on compassionate, personalized, and evidence-based multi-disciplinary care. He is part of the team rotating through the inpatient malignant hematology service at North Shore University Hospital (located on 7 Monti). Dr. Goldberg earned his medical degree at SUNY Downstate College of Medicine. He completed his internal medicine residency and his medical oncology and hematology fellowship at the Northwell Health program located at North Shore University Hospital and Long Island Jewish Medical Center. He is currently an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Goldberg is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration. Dr. Goldberg is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Vinciguerra is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Jaime Andres Suarez Londono, MD, MBA, MS, is the associate director of the adult transplantation and cellular therapy program at Northwell Cancer Institute. After completing medical school in Medellin, Colombia, Dr. Londono did a residency at Columbia University's St Luke's Roosevelt Hospital and a fellowship at Albert Einstein College of Medicine. He then spent eight years as an assistant professor at NYU Langone's Perlmutter Cancer Center, where he held several leadership roles in the NYU Grossman Long Island School of Medicine, and in the stem cell transplant programI was inspired to study hematology, oncology and transplantation because advances in the field are bringing new hope and transforming the lives of our patients in a positive way, says Dr. Londono, who believes that the future of cancer treatment lies in personalized medicine approaches, such as immunotherapy and genetic therapy.Dr. Londono joined Northwell Cancer Institute to continue his research on improving outcomes and expanding access to life saving stem cell transplants and cellular therapies. My goal is to advance the field so we can overcome the challenges of limited donor compatibility and patient eligibility, ensuring more people benefit from transformative treatments, he says.Dr. Londono and his team have authored more than a dozen scientific papers, and his current work is gaining international recognition. Beyond research, he is passionate about public outreach through the American Society of Hematology, serving as co- director of the of Health Volunteers Overseas LATAM. He was honored with the Golden Apple Award from the American Society of Hematology's Health Volunteers Overseas program in recognition of his contributions to global health.Dr. Londono is the founder of a startup dedicated to alleviating physician shortages in the United States. With an eye toward the future, Dr. Londono recently earned an MBA and an MS in Healthcare Leadership from Cornell University. I wanted to study the global healthcare landscape how medicine is delivered in different countries, what lessons we can learn, and the nuances of biotech companies and market dynamics, he explains.Outside of medicine, Dr. Londono pursues his passion for cuisine by taking classes at the American Culinary Institute. Yet his most rewarding moments come at the bedside. My patients are truly 'patient' often spending three or four weeks in the hospital. It's incredibly inspiring to witness their resilience, commitment, and humility. They are the reason I work so hard. Dr. Londono is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Londono is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Mark Atlas is a Pediatric Hematologist Oncology provider practicing medicine in Lake Success, New York. Dr. Atlas is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Optic Glioma, Glioma, Medulloblastoma, and Acute Lymphoblastic Leukemia (ALL). Dr. Atlas is board certified in American Board Of Pediatrics/Hematology-Oncology.

Arlene Redner is a Pediatric Hematologist Oncology provider practicing medicine in New Hyde Park, New York. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Optic Glioma, Acute Lymphoblastic Leukemia (ALL), Classical Hodgkin Lymphoma, and Febrile Neutropenia. Dr. Redner is board certified in American Board Of Pediatrics and American Board Of Pediatrics/Hematology-Oncology.